Evidence map›Paper›PMID 37745691›Full record

ArticleExploration of targeted anti-tumor therapy2023

Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer.

Abhishek Mahajan, Gurukrishna B, Shweta Wadhwa, Ujjwal Agarwal, Ujjwal Baid, Sanjay Talbar, Amit Kumar Janu, Vijay Patil, Vanita Noronha, Naveen Mummudi and 7 more

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Exploration of targeted anti-tumor therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 4 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 1 institution in 2 countries.

Abhishek MahajanClatterbridge Centre for Oncology NHS Foundation Trust, L7 8YA Liverpool, UK.ORCID https://orcid.org/0000-0001-6606-6537
Gurukrishna BDepartment of Radiodiagnosis, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
Shweta WadhwaDepartment of Radiodiagnosis, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
Ujjwal AgarwalDepartment of Radiodiagnosis, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.ORCID https://orcid.org/0000-0001-7414-0696
Ujjwal BaidDepartment of Electronics and Telecommunication Engineering, SGGS Institute of Engineering and Technology, Nanded 431606, Maharashtra, India.
Sanjay TalbarDepartment of Electronics and Telecommunication Engineering, SGGS Institute of Engineering and Technology, Nanded 431606, Maharashtra, India.ORCID https://orcid.org/0000-0002-0111-4910
Amit Kumar JanuDepartment of Radiodiagnosis, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
Vijay PatilDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
Vanita NoronhaDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
Naveen MummudiDepartment of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
Anil TibdewalDepartment of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
J P AgarwalDepartment of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
Subash YadavDepartment of Pathology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
Rajiv Kumar KaushalDepartment of Pathology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.ORCID https://orcid.org/0000-0003-0363-3287
Ameya PuranikDepartment of Nuclear Medicine, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
Nilendu PurandareDepartment of Nuclear Medicine, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
Kumar PrabhashDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
Tata Memorial Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: The aim of this study was to investigate the feasibility of developing a deep learning (DL) algorithm for classifying brain metastases from non-small cell lung cancer (NSCLC) into epidermal growth factor receptor ( Methods: Data set of 117 patients was analysed from 2014 to 2018 out of which 33 patients were Results: In this study of 117 patients, the analysis by semantic method showed 79.2% of the patients belonged to Conclusions: Both semantic features and DL model showed comparable accuracy in classifying

Indexed as

anaplastic lymphoma kinaseconvolutional neural networksdeep learningepidermal growth factor receptormachine learningNon-small cell lung cancerradiomicssemantics

Identifiers

PMID37745691
PMCPMC10511818
OpenAlexW4386270539

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.